2d-Qsar and Molecular Docking based Screening and Anti-Arthritic Activity of Ethanol and Aqueous Extract of Gmelina Arborea

Abstract

Gmelina arborea has been employed for treating rheumatoid arthritis in various traditional systems of medicine. The current study's objective was to use in-silico and in-vivo research to give a scientific basis for G. arborea's ability to treat arthritis. We created a strong 2D-QSAR model to forecast the anti-inflammatory properties of herbal compounds, and the results showed that the compounds found in G. arborea, specifically luteolin, apigenin, stigmasterol, and campesterol, were the most promising ones with strong anti-inflammatory properties. The findings were confirmed by the Molecular Docking investigation, which showed that these compounds had a strong binding relationship with the Janus kinase 3 protein. The Potential of ethanolic extract to reduce inflammation and arthritis and aqueous leaf extract of G. arborea was performed on female Wistar rats. Our results revealed that plant extract is having significant anti-arthritic potential as indicated by the reduction in inflammation and joint stiffness, along with improvement in gait, mobility, and visual weight bearing test along with significant improvement in the hematological profile. It was discovered that the aqueous extract's outcomes were more encouraging than the ethanolic extract's. Our research revealed that G. arborea has high potential as an arthritis preventive, which may be related to the plant's luteolin, apigenin, stigmasterol, and campesterol contents.